Nation & World News

Recall alert: Losartan potassium tablets recall expanded

By Natalie Dreier, Cox Media Group National Content Desk
Jan 23, 2019

Torrent Pharmaceuticals Limited has expanded its recall of Losartan potassium tablets USP. Originally the company recalled 10 lots of the medication. Now company officials have added an additional six lots of Losartan potassium and hydrochlorothiazide tablets after trace amounts of N-nitrosodiethylamine (NDEA) was found in one of the pill's active ingredients, the Food and Drug Administration announced.

>> Read more trending news

NDEA is a naturally occuring substance that is found in some food, water, air pollution and industrial processes. It has been classified as a probable human carcinogen.

The recall only affects products that have more than the acceptable amount of NDEA, according to the FDA.

Patients on the recalled pills are being instructed to continue taking them until they contact their doctor or pharmacist for an alternative treatment, the FDA said in its press release.

Torrent Pharmaceuticals Limited has expanded its recall of Losartan potassium tablets.
Torrent Pharmaceuticals Limited has expanded its recall of Losartan potassium tablets.

The following tablets are covered by the Torrent Pharmaceuticals recall:

Those who may have medical questions about the recall or who want to report a reaction to the medication are being directed to call 1-800-912-9561 or email medinfo.torrent@apcerls.com.

About the Author

Natalie Dreier, Cox Media Group National Content Desk

More Stories